Products for Research Use Only
RegisterLogin

Puxitatug samrotecan

CAT: 0804-HY-171689-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-171689-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Puxitatug samrotecan (AZD8205) is an antibody-drug conjugate (ADC) targeting B7-H4. Puxitatug samrotecan is composed of the Puxitatug antibody targeting B7-H4, randomly conjugated to the Puxitatug samrotecan drug-linker (HY-163487) by reducing inter-chain cysteines. Puxitatug samrotecan has anti-tumor activity and can be used in the study of cancers expressing B7-H4[1].
CAS Number
2760250-80-2
Product Name Alternative
AZD 8205
UNSPSC
12352203
Target
Antibody-Drug Conjugates (ADCs)
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
98.01
Smiles
[Puxitatugsamrotecan]
References & Citations
[1]Kinneer K, et al. Design and Preclinical Evaluation of a Novel B7-H4-Directed Antibody-Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305. Clin Cancer Res. 2023 Mar 14;29 (6) :1086-1101.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C, protect from light
Scientific Category
ADC Related
Clinical Information
Phase 2

Related Products

CatalogName
HY-171124-01Tilatamig samrotecan
HY-P990059-01Puxitatug

Alternative Products

CatalogName
T9901A-948-01Puxitatug samrotecan
GTR18712331-01Puxitatug samrotecan Antibody
T88197-01Puxitatug samrotecan drug-linker
T81345-01Puxitatug
T204443-01Tilatamig samrotecan
GTR18333791-01Puxitatug Antibody
GTR18678987-01Tilatamig samrotecan Antibody
WA3400Research Grade Puxitatug
E55B1055Puxitatug (Reference antibody)
A138157Puxitatug Biosimilar (Monoclonal, IgG1)

Popular Products